Baxter Shares Decline Despite Q3 Earnings Beat and Raised Profit Guidance
Baxter International (BAX) saw its stock price drop approximately 4% during Thursday trading, even after reporting third-quarter financial results that exceeded analyst expectations for both revenue and earnings. The healthcare products company demonstrated improved profitability trends throughout the quarter. In response to the strong performance, Baxter raised its full-year profit guidance. The company now projects adjusted diluted earnings per share (EPS) in the range of $2.05 to $2.15, an increase from its previous outlook of $1.95 to $2.15.
Tickers: $BAX
Topics: earnings beat guidance raise stock price movement
Read the full article at Seeking Alpha
Part of the story FedEx Raises Profit Guidance Despite Post-Market Share Decline (2 articles)